BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

17 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
COMPLEMENT FACTOR B INHIBITORS AND USES THEREOFBDB
Novartis
ANTIBODY-DRUG CONJUGATES COMPRISING GLP1 PEPTIDOMIMETICS AND USES THEREOFBDB
Regeneron Pharmaceuticals
IMIDAZOLE ORGANIC COMPOUNDS AND THEIR USE AGAINST INFLAMMATORY BOWEL DISEASEBDB
Benevolentai Cambridge
Pyrazolopyridinone CompoundsBDB
Beigene
Substituted indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitorsBDB
1St Biotherapeutics
Bicyclic compound and use thereofBDB
Sk Biopharmaceuticals
5 to 7 membered heterocyclic amides as JAK inhibitorsBDB
Theravance Biopharma R&D Ip
Tetrahydroquinoline derivatives and a process of preparation thereofBDB
King Abdulaziz University
Indazole compounds and uses thereofBDB
Incyte
Heterocyclylmethylidene derivatives and their use as modulators of mGluR5 receptorsBDB
Recordati Industria Chimica E Farmacentica
Compounds useful as inhibitors of ATR kinaseBDB
Vertex Pharmaceuticals
Fused imidazo-piperidine JAK inhibitorsBDB
Theravance Biopharma R&D Ip
Substituted imidazo[1,2-A]pyridines as IRAK 1/4 and flt3 inhibitorsBDB
Children''S Hospital Medical Center
Bicyclic heterocycles as FGFR4 inhibitorsBDB
Incyte
Macrocyclic compounds for treatment of medical disordersBDB
Achillion Pharmaceuticals
Cyclopropylamines as LSD1 inhibitorsBDB
Incyte
Methods and compositions for inhibition of bromodomain-containing proteinsBDB
Convergene